Taiwan Emerges as Central Flashpoint in TrumpXi Diplomatic Engagement Crypto Regulation Stalls as Labor Unions Raise Opposition IES Holdings IESC Q1 2026 Earnings Beat Revenue NA EPS 544 Bessent Signals Substantial Disinflation Ahead as Warsh Assumes Fed Leadership US Bank Sees Moderate US Economic Growth Path Amid Policy Crosscurrents Labor Market Trends in Focus The Hamilton Projects Latest Tracking Report Vinyl Revival Gaining Momentum in North Carolinas Plastics Sector Three Oil LNG Tankers Exit Strait of Hormuz with Transponders Off Amid Limited Traffic Barclays Analyzes Market Implications of Embodied AI Bullish or Bearish Trumps Mixed Messaging on Iran Deal Keeps Energy Markets on Edge Greenidge Generation Holdings 850 Senior Notes GREEL Q1 2025 Earnings Narrowed Loss Exceeds Expectations as Stock Reacts Cautiously TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense A10 Networks Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction BDTX Q1 2026 Earnings Narrowed Loss Surprises Yet Stock Declines 358 Presidio Property Trust Q3 2023 Earnings Net Loss Reported Amidst Market Challenges Templeton Dragon Fund TDF Slips as China Markets Remain Under Pressure Sharps Technology Inc STSS Edges Higher Testing Key Resistance at 194 abrdn National Municipal Income Fund VFL Edges Higher as Price Approaches Key Resistance Fox Corporation FOX Holds Near Resistance as Momentum Builds BlackRock Credit Allocation Income Trust BTZ Edges Higher as Income Investors Test Resistance PowerFleet Inc AIOT Surges 396 as Stock Tests Key Resistance Levels First Industrial Realty Trust FR Edges Lower Amid Consolidation Octave Specialty Group Inc OSG Slips 125 as Selling Pressure Tests NearTerm Support Global Net Lease Inc GNL Edges Lower as Investors Weigh Real Estate Sector Pressures Xtant Medical Holdings XTNT Gains 208 as Stock Approaches Key Resistance at 050 Solid Biosciences SLDB Rallies 37 as Stock Approaches Key Resistance at 720 Quantinuum Files for IPO Quantum Computing Startup Targets 13 Billion Valuation Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses LCNB Corporation Holds Steady Near Support as Market Awaits Direction